UPLOAD Filing
Dermata Therapeutics, Inc.
Date: April 21, 2025 · CIK: 0001853816 · Accession: 0000000000-25-004185
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286547
Letter
Re: Dermata Therapeutics, Inc. Registration Statement on Form S-3 Filed April 15, 2025 File No. 333-286547 Dear Gerald Proehl:
April 21, 2025
Gerald Proehl Chief Executive Officer Dermata Therapeutics, Inc. 3525 Del Mar Heights Rd., #322 San Diego, CA 92130
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Steven M. Skolnick, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 21, 2025 Gerald Proehl Chief Executive Officer Dermata Therapeutics, Inc. 3525 Del Mar Heights Rd., #322 San Diego, CA 92130 Re: Dermata Therapeutics, Inc. Registration Statement on Form S-3 Filed April 15, 2025 File No. 333-286547 Dear Gerald Proehl: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven M. Skolnick, Esq. </TEXT> </DOCUMENT>